Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Therapeutic applications of lysostaphin against Staphylococcus aureus

31 Dec 2020

Abstract excerpt

Staphylococcus aureus, an opportunistic pathogen, causes diverse community and nosocomial-acquired human infections, including folliculitis, impetigo, sepsis, septic arthritis, endocarditis, osteomyelitis, implant-associated biofilm infections and contagious mastitis in cattle. In recent days, both methicillin-sensitive and methicillin-resistant S. aureus infections have increased. Highly effective...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antimicrobial Resistance in Staphylococcus
Share to Bacterial biofilms and quorum sensing
Share to Microbial Metabolism and Applications

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 33382154
DOI: 10.1111/jam.14985

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 5 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Therapeutic applications of lysostaphin against Staphylococcus aureusPMID 33382154Read ↗

Crystal structure of the antimicrobial peptidase lysostaphin from Staphylococcus simulansSemantic proximity Read ↗

Staphylococcus simulans recombinant lysostaphin: Production, purification, and determination of antistaphylococcal activitySemantic proximity Read ↗

Exploring Staphylococcus aureus Virulence Factors; Special Emphasis on StaphyloxanthinSemantic proximity Read ↗

Fusion with a cell wall binding domain renders autolysin LytM a potent anti-Staphylococcus aureus agentSemantic proximity Read ↗

MEndoB, a chimeric lysin featuring a novel domain architecture and superior activity for the treatment of staphylococcal infectionsSemantic proximity Read ↗

Sortase A Inhibition: Updated Review of Non-Peptide Ligands for Targeting Staphylococcus Aureus VirulenceSemantic proximity Read ↗

VISLISI trial, a prospective clinical study allowing identification of a new metalloprotease and putative virulence factor from Staphylococcus lugdunensisSemantic proximity Read ↗

Are Phage Lytic Proteins the Secret Weapon To Kill Staphylococcus aureus ?Semantic proximity Read ↗

Anti-virulence potential of iclaprim, a novel folic acid synthesis inhibitor, against Staphylococcus aureusSemantic proximity Read ↗

LytM Fusion with SH3b-Like Domain Expands Its Activity to Physiological Conditions.Semantic proximity Read ↗

A comprehensive review of pathology and treatment of staphylococcus aureus osteomyelitisSemantic proximity Read ↗

Tamarixetin Attenuated the Virulence of Staphylococcus aureus by Directly Targeting Caseinolytic Protease PSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.